Inspire Medical Systems, Inc. (NYSE: INSP) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $280.00 price target on the stock.
MediumReport
Inspire Medical Systems, Inc. (NYSE: INSP) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $280.00 price target on the stock.
Inspire Medical Systems, Inc. (NYSE: INSP) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $250.00 price target on the stock.
LowReport
Inspire Medical Systems, Inc. (NYSE: INSP) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $250.00 price target on the stock.
INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
LowReport
INSPIRE MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: